Colony Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $7.33M | Buy |
16,832
+174
| +1% | +$78.9K | 0.11% | 175 |
|
|
2023
Q2 | $7.4M | Sell |
16,658
-368
| -2% | -$170K | 0.11% | 183 |
|
|
2023
Q1 | $7.83M | Sell |
17,026
-2,101
| -11% | -$1,000K | 0.12% | 179 |
|
|
2022
Q4 | $9.81M | Sell |
19,127
-306
| -2% | -$155K | 0.14% | 149 |
|
|
2022
Q3 | $8.83M | Buy |
19,433
+548
| +3% | +$262K | 0.16% | 138 |
|
|
2022
Q2 | $9.11M | Buy |
18,885
+6,341
| +51% | +$3.14M | 0.16% | 137 |
|
|
2022
Q1 | $6.16M | Buy |
12,544
+8,614
| +219% | +$3.94M | 0.09% | 197 |
|
|
2021
Q4 | $1.82M | Sell |
3,930
-517
| -12% | -$218K | 0.03% | 340 |
|
|
2021
Q3 | $1.66M | Sell |
4,447
-102
| -2% | -$38.8K | 0.03% | 342 |
|
|
2021
Q2 | $1.74M | Sell |
4,549
-177
| -4% | -$67.6K | 0.03% | 313 |
|
|
2021
Q1 | $1.7M | Sell |
4,726
-362
| -7% | -$116K | 0.04% | 323 |
|
|
2020
Q4 | $1.63M | Sell |
5,088
-820
| -14% | -$252K | 0.04% | 296 |
|
|
2020
Q3 | $1.59M | Sell |
5,908
-76
| -1% | -$20.4K | 0.04% | 294 |
|
|
2020
Q2 | $1.57M | Sell |
5,984
-151
| -2% | -$40.3K | 0.05% | 282 |
|
|
2020
Q1 | $1.39M | Sell |
6,135
-690
| -10% | -$188K | 0.05% | 287 |
|
|
2019
Q4 | $2.06M | Buy |
6,825
+4,257
| +166% | +$1.17M | 0.05% | 291 |
|
|
2019
Q3 | $617K | Sell |
2,568
-4,424
| -63% | -$1.21M | 0.02% | 455 |
|
|
2019
Q2 | $1.97M | Buy |
6,992
+4,418
| +172% | +$1.21M | 0.06% | 280 |
|
|
2019
Q1 | $739K | Buy |
2,574
+159
| +7% | +$46K | 0.03% | 329 |
|
|
2018
Q4 | $634K | Sell |
2,415
-264
| -10% | -$72.6K | 0.03% | 313 |
|
|
2018
Q3 | $734K | Sell |
2,679
-109
| -4% | -$28.3K | 0.04% | 295 |
|
|
2018
Q2 | $664K | Sell |
2,788
-117
| -4% | -$27.1K | 0.03% | 302 |
|
|
2018
Q1 | $638K | Buy |
2,905
+214
| +8% | +$50.3K | 0.03% | 297 |
|
|
2017
Q4 | $606K | Buy |
2,691
+204
| +8% | +$43.4K | 0.04% | 288 |
|
|
2017
Q3 | $472K | Buy |
2,487
+584
| +31% | +$111K | 0.03% | 300 |
|
|
2017
Q2 | $358K | Buy |
+1,903
| New | +$342K | 0.03% | 321 |
|
|
2016
Q1 | – | Sell |
-685
| Closed | -$96K | – | 360 |
|
|
2015
Q4 | $96K | Hold |
685
| – | – | 0.01% | 428 |
|
|
2015
Q3 | $96K | Sell |
685
-221
| -24% | -$33.2K | 0.01% | 409 |
|
|
2015
Q2 | $149K | Buy |
906
+221
| +32% | +$35.3K | 0.02% | 380 |
|
|
2015
Q1 | $106K | Buy |
685
+25
| +4% | +$3.56K | 0.01% | 357 |
|
|
2014
Q4 | $83K | Hold |
660
| – | – | 0.01% | 395 |
|
|
2014
Q3 | $79K | Buy |
660
+85
| +15% | +$9.75K | 0.01% | 381 |
|
|
2014
Q2 | $62K | Buy |
575
+50
| +10% | +$5.15K | 0.01% | 315 |
|
|
2014
Q1 | $52K | Buy |
+525
| New | +$47.5K | 0.01% | 323 |
|
Other funds holding ELV
Colony Group's ELV Position: Q3 2023 in Review
Colony Group increased its Elevance Health (ELV) stake by 1% in Q3 2023, buying an estimated $78.9K and bringing the position to 16,832 shares worth $7.33M. The position accounts for 0.11% of the portfolio, ranked #175.
Colony Group first reported a position in ELV in Q1 2014 and has held it in 34 quarters since. The position peaked at $9.81M in Q4 2022. 1,524 funds tracked by Wall St. Rank hold ELV as of Q3 2023.
- Colony Group held 16,832 shares of Elevance Health worth $7.33M as of Q3 2023.
- Colony Group bought 174 Elevance Health shares in Q3 2023, an estimated $78.9K.
- Elevance Health made up 0.11% of Colony Group's portfolio in Q3 2023, its #175 holding.
- Colony Group first reported a position in Elevance Health in Q1 2014 and has held it in 34 quarters since.
- Colony Group's Elevance Health position peaked at $9.81M in Q4 2022.
- 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.